Answers are grounded in this paper and cite their sources.
Parkinson’s Disease (PD) is a prevalent movement disorder among the population with more than 10 million living with PD worldwide. L-DOPA has been a drug of choice in the treatment of PD for a long time due to its potential to cross the blood-brain barrier. However, prolonged use of synthetic L-DOPA also exerted toxicities in the patients. A significant number of research studies have been documented for a promising future of using natural L-DOPA resources for the management of PD or perhaps delaying the onset of PD. This review will highlight the potential of some of the natural L-DOPA sources and neuroprotective agents used in PD management.
No takes yet. Share an insight, caveat, or question.
Arif et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: